George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMirriad Advertising Regulatory News (MIRI)

Share Price Information for Mirriad Advertising (MIRI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.00
Bid: 1.95
Ask: 2.05
Change: 0.145 (7.95%)
Spread: 0.10 (5.128%)
Open: 1.825
High: 1.97
Low: 1.97
Prev. Close: 1.825
MIRI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OTC listing

9 Sep 2020 07:00

RNS Number : 3850Y
Mirriad Advertising PLC
09 September 2020
 

9 September 2020

 

 

Mirriad Advertising plc

 

("Mirriad" or the "Group")

 

Mirriad cross lists its shares on the New York OTCQB® Market

 

Mirriad, the computer vision, technology and AI platform company, is pleased to announce it has qualified for trading on the OTCQB® ("OTCQB Market") in the United States operated by OTC Markets Group Inc ("OTC Market"). Mirriad's ordinary shares of £0.00001 each ("Ordinary Shares") will commence trading today on the OTCQB Market under the ticker symbol "MMDDF". Mirriad's Ordinary Shares will continue to trade on the London Stock Exchange's AIM market under the symbol "MIRI".

 

Leading the strategic turnaround of the business, Stephan Beringer, CEO of Mirriad, said:

"This is a key stage in Mirriad's development as we drive increased adoption amongst top-tier partners. We know audiences actively prefer our format and the focus is now on scaling the business, building on our unique ability to create brand new revenue streams for advertisers, broadcasters and content creators.

 

"This listing marks another important step in our strategic plan to access investors interested in the growth journey of Mirriad as we reach new audiences."

 

The listing on the OTCQB Market will allow Mirriad's Ordinary Shares to be traded by broker-dealers in the United States. To manage demand, Canaccord Genuity LLC and Mirriad's retained Nominated Adviser & Broker, Canaccord Genuity Limited, will act as market makers in the United States and in the UK.

 

Speaking of the strategic step made by Mirriad, Jonathan Dickson, VP of International Corporate Services at OTC Markets, said:

"We are delighted to welcome Mirriad Advertising plc to the OTCQB Market. With its primary listing remaining on AIM, the OTCQB Market cross trading facility will provide investors in the United States with the ability to access Mirriad's Ordinary Shares in U.S dollars during U.S market hours.

 

"The OTC Market supports international companies seeking to strengthen visibility and transparency in the U.S. public market. Trading on AIM and on the OTCQB Market will enable Mirriad to efficiently build global investor awareness and provide U.S investors with a seamless trading facility, enabling investors to more easily trade through the broker of their choice."

 

Mirriad will announce its half-yearly results for the six months ended 30 June 2020, tomorrow on Thursday, 10 September 2020.

 

John Pearson, Chairman of Mirriad, Stephan Beringer, CEO, and David Dorans, CFO, will host a webinar for analysts and investors at 09.30 BST on 10 September 2020 to provide a briefing presentation following the release of the Group's interim results. If you would like to attend, please contact mirriad@charlottestpartners.co.uk to register and receive dial-in details.

 

For US and Global investors, a webinar will be hosted by Edison Research on Sept 15 at 10:30am EST, to join please contact Olivia Beaman on olivia.beaman@mirriad.com 

 

 

ENDS

 

For further information please visit www.mirriad.com or contact:

 

Mirriad Advertising plc.

Stephan Beringer, Chief Executive Officer

Tel: +44 (0)207 884 2530

David Dorans, Chief Financial Officer

 

 

Nominated Adviser & Broker: Canaccord Genuity Limited

Simon Bridges

Tel: +44 (0)20 7523 8000

Richard Andrews

 

Thomas Diehl

 

 

Financial Communications: Charlotte Street Partners

Tom Gillingham

Tel: +44 (0) 7741 659021

Katie Stanton

Tel: +44 (0) 7789 204508

 

OTC Strategic Advisor: Lansdown Strategic Capital

Ryan Mendy

Tel: +44 (0) 7760 20 1995

 

US Listing: OTC Markets Group:

Jonathan Dickson

Tel: +44 (0) 20 3950 7235

 

 

Notes to editors

 

 

About Mirriad

 

Mirriad's award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad's market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions.

 

Mirriad currently operates in the US, Europe and China.

 

 

About the OTC

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, OTC Markets connect a diverse network of broker-dealers that provide liquidity and execution services. This enables investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

 

OTC Markets Group is the U.S home to many of the world's largest established brands such as Roche, adidas, Heineken, Marks & Spencer's and Danone.

 

ENDS

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSLPMATMTTMBBM
Date   Source Headline
7th May 20201:48 pmRNSMirriad sees returning Chinese consumer confidence
6th May 20202:45 pmRNSNotice of analyst and investor webinar
2nd Apr 20207:00 amRNSDirector dealing
19th Mar 20207:00 amRNSMarket Update
5th Mar 20207:00 amRNSCorporate Broker Appointment
5th Feb 20207:00 amRNSYear-end trading update
17th Dec 20197:00 amRNSMirriad technology showcase and newsletter
22nd Oct 20194:00 pmRNSHolding(s) in Company
22nd Oct 20194:00 pmRNSHolding(s) in Company
12th Sep 20197:00 amRNS2019 interim results and report
5th Sep 20197:00 amRNSNotice of Analyst and Investor Webinar
19th Aug 20194:41 pmRNSSecond Price Monitoring Extn
19th Aug 20194:35 pmRNSPrice Monitoring Extension
19th Aug 20192:25 pmRNSHolding(s) in Company
6th Aug 20193:52 pmRNSHolding(s) in Company
2nd Aug 201912:46 pmRNSHolding(s) in Company
2nd Aug 201911:50 amRNSHolding(s) in Company
1st Aug 20192:28 pmRNSDirector/PDMR Shareholding
31st Jul 20195:51 pmRNSResult of Rump Placing
31st Jul 201911:48 amRNSGM Statement
31st Jul 20197:00 amRNSResult of open offer
5th Jul 20197:00 amRNSMirriad Trading Update
5th Jul 20197:00 amRNSUpdate on Fundraising and Posting of Circular
28th Jun 20197:00 amRNSMIRRIAD SIGNS NEW CONTRACT WITH TENCENT
14th Jun 20197:00 amRNSApproval of resolutions at AGM
4th Jun 20197:00 amRNSDirectorate Change
17th May 20197:00 amRNSAnnual Report and Accounts and Notice of AGM
16th May 20193:48 pmRNSLong Term Incentive Plan
9th May 20197:00 amRNSFinal Results
30th Apr 20197:00 amRNSDirectorate Change
28th Mar 201910:43 amRNSHolding(s) in Company
27th Mar 20197:00 amRNSStrategy Update
25th Mar 20197:00 amRNSCompany Strategic Update
12th Nov 20187:00 amRNSLong Term Incentive Plan & Director Dealing
9th Nov 20187:00 amRNSMirriad signs contract with TF1
1st Oct 201812:13 pmRNSLong Term Incentive Plan & Director Dealing
1st Oct 20187:00 amRNSAppointment of Jana Eisenstein
27th Sep 20187:01 amRNSDirectorate Change
27th Sep 20187:00 amRNSUnaudited Interim Results
26th Jul 20187:00 amRNSMirriad signs contract with Tencent
13th Jun 201811:48 amRNSResults of AGM
18th May 20189:34 amRNSAnnual Report and Accounts and Notice of AGM
9th May 20187:00 amRNSResults for the year ended 31 December 2017
1st May 20187:00 amRNSMirriad signs contract with El Cartel
27th Apr 20189:49 amRNSHolding(s) in Company
25th Apr 201810:18 amRNSNotice of results and statement re share price
24th Apr 201810:09 amRNSCompletion of Investment by Jinhua Puhua Tianqin
12th Apr 20187:00 amRNSMirriad renews contract with Star India
12th Mar 20182:15 pmRNSHolding(s) in Company
6th Feb 20189:10 amRNSMirriad signs contract with NBCU

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.